<DOC>
	<DOCNO>NCT01254799</DOCNO>
	<brief_summary>This study aim test effect Doxycycline treatment uterine bleeding use injectable contraception contain one hormone `` progesterone '' .</brief_summary>
	<brief_title>Doxycycline Treatment Bleeding With Depot Medroxyprogesterone Acetate ( DMPA )</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>1 . Women DMPA contraception least one month . 2 . Accept participate trial receive adequate information trial include information part randomization comprise possibility receive new treatment bleed inactive ingredient . 3 . Women 's ability keep accurate menstrual diary study . 1 . Lactating woman fear effect tetracycline breastfed infant . 2 . Patients already diagnose local gynecological abnormality . 3 . Women receive treatment bleed within last one month .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>